癌症单株抗体的全球市场调查报告-产业分析，规模，占有率，成长，趋势，2022年～2028年前的预测

Value Market Research深入调查癌症单株抗体的全球市场，并预测未来几年行业将出现显着增长。本研究报告提供全球癌症单株抗体市场相关之完全产业分析，提供市场规模、市场占有率、增长趋势、2023年至2028年的预测等。该报告以详细的市场介绍和突出报告关键增长数据的执行摘要为首。接续的章节讨论市场价值链、波特五力模型和市场吸引力分析。同时还设立关于COVID-19影响分析的独立章节，以了解市场如何应对疫情。

本报告的市场动态部分详细介绍了当前的市场推动因素/阻碍、课题/风险和未来机遇。本节对企业战略家和新产品开发部门非常有用。癌症单株抗体全球市场调查将市场细分化，并根据收益和/或销售额的视点提供市场规模。该数据地区细分，同时国家/地区细分。数据是通过深入的初级访谈和世界各地的行业专家收集而来。详细的调查方法可以在样本报告中找到。这些市场预测受到最新的社会、政治和经济变化以及影响该癌症单株抗体市场的当前市场动态所影响。

癌症单株抗体市场报告的子章节提供市场竞争力调查，提供一些领先的市场参与者/製造商简介。这些章节涵括可深入了解竞争对手的产品线、财务状况、最新发展以及在行业中拥有最高市场占有率公司所需的丰富资讯。

目录

第1章 序文

• 本报告的内容
  • 目的
  • 主要读者
  • 独特的销售主张(USP)和报价环
• 调查范围
• 调查手法
  • 市场调查流程
  • 市场调查手法

第2章 摘要整理

• 市场概况
• 全球市场的概述

第3章 癌症单株抗体:产业分析

• 简介- 市场动态
• 推动市场要素
• 阻碍市场要素
• 商机
• 产业趋势
• 波特的五力分析
• 市场魅力分析
  • 各类型
  • 各药物类型
  • 各应用领域
  • 各终端用户
  • 各地区

第4章 价值链分析

• 价值链分析
• 原料的分析
  • 原料一览
  • 原料的製造原清单
  • 主要原料的价格趋势
• 潜在的买主清单
• 销售管道
  • 直销
  • 间接行销
  • 行销流通管道的开发趋势

第5章 COVID-19疫情的影响分析

• COVID-19疫情影响分析
  • 对生产的直接性影响
  • 供应链与市场的混乱
  • 对企业及金融市场的财务影响
• COVID-19生产，进口，出口，各需求的影响分析
• 市场COVID-19疫情前/发生后
• 冠状病毒(COVID-19)疫情的影响预测
• COVID-19:微观和宏观的要素分析

第6章 癌症单株抗体的全球市场分析:各类型

• 各类型概要
• 实际成果资料与预测资料
• 各类型分析
• 鼠标抗体的各地区市场
• 嵌合抗体的各地区市场
• 人体化抗体的各地区市场
• 其他的各地区市场

第7章 癌症单株抗体的全球市场分析:各药物类型

• 各药物类型概要
• 实际成果资料与预测资料
• medikeshontaipu分析
• Bevacizumab(Avastin)各地区市场转变
• Rituximab(Rituxan)各地区市场
• Trastuzumab(Herceptin)的各地区市场
• Cetuximab(Erbitux)各地区市场
• Panitumumab(Vectibix)的各地区市场
• 其他各地区市场

第8章 癌症单株抗体的全球市场分析:各用途

• 各应用领域概要
• 实际成果资料与预测资料
• 各应用领域分析
• 乳癌的各地区市场
• 血液癌症的各地区市场
• 肝臟癌症的各地区市场
• 脑瘤的各地区市场
• 大肠癌症的各地区市场
• 其他的各地区市场

第9章 癌症单株抗体的全球市场分析:各终端用户

• 各终端用户概要
• 实际成果资料与预测资料
• 各终端用户分析
• 医院·诊所的各地区市场
• 药局的各地区市场
• 研究所的各地区市场
• 其他各地区市场

第10章 癌症单株抗体的全球市场分析:各地区

• 各地区展望
• 简介
• 北美
  • 概要，过去实际成果与预测资料
  • 北美的各市场区隔资料
  • 北美的各国资料
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 概要，过去实际成果与预测资料
  • 欧洲的各市场区隔
  • 欧洲的各国资料
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他的欧洲地区
• 亚太地区
  • 概要，过去实际成果与预测资料
  • 亚太地区的各市场区隔
  • 亚太地区的各国资料
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 其他亚太地区
• 南美
  • 概要，过去实际成果与预测资料
  • 南美:各市场区隔
  • 南美:各国资料
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他的南美地区
• 中东·非洲地区
  • 概要，过去实际成果与预测资料
  • 中东·非洲地区的各市场区隔
  • 中东·非洲地区的各国资料
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他的中东·非洲地区

第11章 癌症单株抗体企业的竞争情形

• 癌症单株抗体市场竞争
• 联盟·共同研究·协定
• 合併·收购
• 新产品上市
• 其他的开发

第12章 企业简介

• 企业占有率分析
• 市场集中度
• AbbVie Inc.
  • 企业概要
  • 产品介绍
  • 最近的开发情形
• Amgen Inc.
  • 公司概要
  • 产品介绍
  • 最近的开发情形
• Bristol-Myers Squibb Company
  • 公司概要
  • 产品资讯
  • 最近的开发情形
• Eli Lilly and Company
  • 公司概要
  • 产品资讯
  • 最近的开发情形
• Genmab A/S
  • 公司概要
  • 产品资讯
  • 最近的开发情形
• GlaxoSmithKline Plc.
  • 公司概要
  • 产品资讯
  • 最近的开发情形
• Johnson & Johnson
  • 公司概要
  • 产品资讯
  • 最近的开发情形
• Merck & Co. Inc.
  • 公司概要
  • 产品资讯
  • 最近的开发情形
• Novartis AG
  • 公司概要
  • 产品资讯
  • 最近的开发情形
• Pfizer Inc.
  • 公司概要
  • 产品资讯
  • 最近的开发情形
• Roche Holding AG
  • 公司概要
  • 产品资讯
  • 最近的开发情形
• Seattle Genetics Inc.
  • 公司概要
  • 产品资讯
  • 最近的开发情形
• Spectrum Pharmaceuticals Inc.
  • 公司概要
  • 产品资讯
  • 最新资讯

在公司简介中，财务细节和最近的发展基于可取得的现有信息，可能不包含非上市公司。

Value Market Research deeply researched the Global Cancer Monoclonal Antibodies Market to foresee a significant growth in the industry over the upcoming years. The global cancer monoclonal antibodies market report provides a complete industry analysis, market size, market share, growth trends, and forecasts for 2023 to 2028. The report starts with a detailed market introduction and an executive summary that highlights the report's key growth numbers. The subsequent chapters discuss the value chain of the market, Porter's Five Forces Model, and market attractiveness analysis. An exclusive chapter on COVID-19 impact analysis has been added to understand how the market has responded to the pandemic.

The market dynamics section of the report elaborates the current market drivers, restraints along with the challenges/risks and upcoming opportunities. This section can be of high interest for any company's strategists and new product development department. The global cancer monoclonal antibodies market study segments the market and provides the market size in terms of revenue and/ or sales. This data is bifurcated by region and later by countries. The data is collected through detailed primary interviews and industry experts across the world. The detailed methodology can be seen in our sample reports. These market estimates are also influenced by the latest social, political and economic changes along with the current market dynamics that are affecting this cancer monoclonal antibodies market.

The next sections of the cancer monoclonal antibodies market report studies the market competitiveness and profiles some key market players/manufacturers. These sections are knowledgeable for understanding the competitor's product-line, their financials, recent developments and the top market share owners in the industry.

Countries Covered in the report are as below:

• North America: United States, Canada, and Mexico

• Europe: United Kingdom, Germany, France, Italy, Russia, Spain & Rest of Europe

• Asia-Pacific: China, India, Japan, South Korea, Australia & Rest of APAC

• Latin America: Brazil, Argentina, Peru, Chile & Rest of Latin America

• Middle East and Africa: Saudi Arabia, UAE, Israel, South Africa

Market Segmentation in the report is as below:

By Type

• Murine Antibodies
• Chimeric Antibodies
• Humanized Antibodies
• Others

By Medication Type

• Bevacizumab (Avastin)
• Rituximab (Rituxan)
• Trastuzumab (Herceptin)
• Cetuximab (Erbitux)
• Panitumumab (Vectibix)
• Others

By Application

• Breast Cancer
• Blood Cancer
• Liver Cancer
• Brain Cancer
• Colorectal Cancer
• Others

By End-User

• Hospitals And Clinics
• Pharmacies
• Research Laboratories
• Others

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . CANCER MONOCLONAL ANTIBODIES - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 By Type
  • 3.7.2 By Medication Type
  • 3.7.3 By Application
  • 3.7.4 By End-User
  • 3.7.5 By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

• 5.1. Impact Analysis of Covid-19 Outbreak
  • 5.1.1. Direct Impact on Production
  • 5.1.2. Supply Chain and Market Disruption
  • 5.1.3. Financial Impact on Firms and Financial Markets
• 5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
• 5.3. Market: Pre V/S Post COVID-19
• 5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
• 5.5. COVID-19: Micro and Macro Factor Analysis

6 . GLOBAL CANCER MONOCLONAL ANTIBODIES MARKET ANALYSIS BY TYPE

• 6.1 Overview by Type
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Type
• 6.4 Murine Antibodies Market by Regions
• 6.5 Chimeric Antibodies Market by Regions
• 6.6 Humanized Antibodies Market by Regions
• 6.7 Others Market by Regions

7 . GLOBAL CANCER MONOCLONAL ANTIBODIES MARKET ANALYSIS BY MEDICATION TYPE

• 7.1 Overview by Medication Type
• 7.2 Historical and Forecast Data
• 7.3 Analysis by Medication Type
• 7.4 Bevacizumab (Avastin) Market by Regions
• 7.5 Rituximab (Rituxan) Market by Regions
• 7.6 Trastuzumab (Herceptin) Market by Regions
• 7.7 Cetuximab (Erbitux) Market by Regions
• 7.8 Panitumumab (Vectibix) Market by Regions
• 7.9 Others Market by Regions

8 . GLOBAL CANCER MONOCLONAL ANTIBODIES MARKET ANALYSIS BY APPLICATION

• 8.1 Overview by Application
• 8.2 Historical and Forecast Data
• 8.3 Analysis by Application
• 8.4 Breast Cancer Market by Regions
• 8.5 Blood Cancer Market by Regions
• 8.6 Liver Cancer Market by Regions
• 8.7 Brain Cancer Market by Regions
• 8.8 Colorectal Cancer Market by Regions
• 8.9 Others Market by Regions

9 . GLOBAL CANCER MONOCLONAL ANTIBODIES MARKET ANALYSIS BY END-USER

• 9.1 Overview by End-User
• 9.2 Historical and Forecast Data
• 9.3 Analysis by End-User
• 9.4 Hospitals and Clinics Market by Regions
• 9.5 Pharmacies Market by Regions
• 9.6 Research Laboratories Market by Regions
• 9.7 Others Market by Regions

10 . GLOBAL CANCER MONOCLONAL ANTIBODIES MARKET ANALYSIS BY GEOGRAPHY

• 10.1. Regional Outlook
• 10.2. Introduction
• 10.3. North America
  • 10.3.1. Overview, Historic and Forecast Data
  • 10.3.2. North America By Segment
  • 10.3.3. North America By Country
  • 10.3.4. United State
  • 10.3.5. Canada
  • 10.3.6. Mexico
• 10.4. Europe
  • 10.4.1. Overview, Historic and Forecast Data
  • 10.4.2. Europe by Segment
  • 10.4.3. Europe by Country
  • 10.4.4. United Kingdom
  • 10.4.5. France
  • 10.4.6. Germany
  • 10.4.7. Italy
  • 10.4.8. Russia
  • 10.4.9. Rest Of Europe
• 10.5. Asia Pacific
  • 10.5.1. Overview, Historic and Forecast Data
  • 10.5.2. Asia Pacific by Segment
  • 10.5.3. Asia Pacific by Country
  • 10.5.4. China
  • 10.5.5. India
  • 10.5.6. Japan
  • 10.5.7. South Korea
  • 10.5.8. Australia
  • 10.5.9. Rest Of Asia Pacific
• 10.6. Latin America
  • 10.6.1. Overview, Historic and Forecast Data
  • 10.6.2. Latin America by Segment
  • 10.6.3. Latin America by Country
  • 10.6.4. Brazil
  • 10.6.5. Argentina
  • 10.6.6. Peru
  • 10.6.7. Chile
  • 10.6.8. Rest of Latin America
• 10.7. Middle East & Africa
  • 10.7.1. Overview, Historic and Forecast Data
  • 10.7.2. Middle East & Africa by Segment
  • 10.7.3. Middle East & Africa by Country
  • 10.7.4. Saudi Arabia
  • 10.7.5. UAE
  • 10.7.6. Israel
  • 10.7.7. South Africa
  • 10.7.8. Rest Of Middle East And Africa

11 . COMPETITIVE LANDSCAPE OF THE CANCER MONOCLONAL ANTIBODIES COMPANIES

• 11.1. Cancer Monoclonal Antibodies Market Competition
• 11.2. Partnership/Collaboration/Agreement
• 11.3. Merger And Acquisitions
• 11.4. New Product Launch
• 11.5. Other Developments

12 . COMPANY PROFILES OF CANCER MONOCLONAL ANTIBODIES INDUSTRY

• 12.1. Company Share Analysis
• 12.2. Market Concentration Rate
• 12.3. AbbVie Inc.
  • 12.3.1. Company Overview
  • 12.3.2. Financials
  • 12.3.3. Products
  • 12.3.4. Recent Developments
• 12.4. Amgen Inc.
  • 12.4.1. Company Overview
  • 12.4.2. Financials
  • 12.4.3. Products
  • 12.4.4. Recent Developments
• 12.5. Bristol-Myers Squibb Company
  • 12.5.1. Company Overview
  • 12.5.2. Financials
  • 12.5.3. Products
  • 12.5.4. Recent Developments
• 12.6. Eli Lilly and Company
  • 12.6.1. Company Overview
  • 12.6.2. Financials
  • 12.6.3. Products
  • 12.6.4. Recent Developments
• 12.7. Genmab A/S
  • 12.7.1. Company Overview
  • 12.7.2. Financials
  • 12.7.3. Products
  • 12.7.4. Recent Developments
• 12.8. GlaxoSmithKline Plc.
  • 12.8.1. Company Overview
  • 12.8.2. Financials
  • 12.8.3. Products
  • 12.8.4. Recent Developments
• 12.9. Johnson & Johnson
  • 12.9.1. Company Overview
  • 12.9.2. Financials
  • 12.9.3. Products
  • 12.9.4. Recent Developments
• 12.10. Merck & Co. Inc.
  • 12.10.1. Company Overview
  • 12.10.2. Financials
  • 12.10.3. Products
  • 12.10.4. Recent Developments
• 12.11. Novartis AG
  • 12.11.1. Company Overview
  • 12.11.2. Financials
  • 12.11.3. Products
  • 12.11.4. Recent Developments
• 12.12. Pfizer Inc.
  • 12.12.1. Company Overview
  • 12.12.2. Financials
  • 12.12.3. Products
  • 12.12.4. Recent Developments
• 12.13. Roche Holding AG
  • 12.13.1. Company Overview
  • 12.13.2. Financials
  • 12.13.3. Products
  • 12.13.4. Recent Developments
• 12.14. Seattle Genetics Inc.
  • 12.14.1. Company Overview
  • 12.14.2. Financials
  • 12.14.3. Products
  • 12.14.4. Recent Developments
• 12.15. Spectrum Pharmaceuticals Inc.
  • 12.15.1. Company Overview
  • 12.15.2. Financials
  • 12.15.3. Products
  • 12.15.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers : Impact Analysis
• Restraints : Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• List of Potential Buyers
• COVID-19 Impact Analysis by Production, Import, Export and Demand
• Pre V/S Post COVID-19
• Estimated Impact Of The Coronavirus (Covid-19) Epidemic
• COVID-19: Micro and Macro Factor Analysis
• Analysis by Type (USD MN)
• Murine Antibodies Market by Geography (USD MN)
• Chimeric Antibodies Market by Geography (USD MN)
• Humanized Antibodies Market by Geography (USD MN)
• Others Market by Geography (USD MN)
• Analysis Market by Medication Type (USD MN)
• Bevacizumab (Avastin) Market by Geography (USD MN)
• Rituximab (Rituxan) Market by Geography (USD MN)
• Trastuzumab (Herceptin) Market by Geography (USD MN)
• Cetuximab (Erbitux) Market by Geography (USD MN)
• Panitumumab (Vectibix) Market by Geography (USD MN)
• Others Market by Geography (USD MN)
• Analysis by Application (USD MN)
• Breast Cancer Market by Geography (USD MN)
• Blood Cancer Market by Geography (USD MN)
• Liver Cancer Market by Geography (USD MN)
• Brain Cancer Market by Geography (USD MN)
• Colorectal Cancer Market by Geography (USD MN)
• Others Market by Geography (USD MN)
• Analysis by End-User (USD MN)
• Hospitals and Clinics Market by Geography (USD MN)
• Pharmacies Market by Geography (USD MN)
• Research Laboratories Market by Geography (USD MN)
• Others Market by Geography (USD MN)
• Global Cancer Monoclonal Antibodies Market by Geography (USD MN)
• North America Market Analysis (USD MN)
• United State Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate by Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisiton

LIST OF FIGURES

• Research Scope of Cancer Monoclonal Antibodies Report
• Market Research Process
• Market Research Methodology
• Global Cancer Monoclonal Antibodies Market Size, by Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis by Type
• Market Attractiveness Analysis by Medication Type
• Market Attractiveness Analysis by Application
• Market Attractiveness Analysis by End-User
• Market Attractiveness Analysis by Region
• Value Chain Analysis
• Global Market Analysis by Type (USD MN)
• Murine Antibodies Market by Geography (USD MN)
• Chimeric Antibodies Market by Geography (USD MN)
• Humanized Antibodies Market by Geography (USD MN)
• Others Market by Geography (USD MN)
• Global Market Analysis by Medication Type (USD MN)
• Bevacizumab (Avastin) Market by Geography (USD MN)
• Rituximab (Rituxan) Market by Geography (USD MN)
• Trastuzumab (Herceptin) Market by Geography (USD MN)
• Cetuximab (Erbitux) Market by Geography (USD MN)
• Panitumumab (Vectibix) Market by Geography (USD MN)
• Others Market by Geography (USD MN)
• Global Market Analysis by Application (USD MN)
• Breast Cancer Market by Geography (USD MN)
• Blood Cancer Market by Geography (USD MN)
• Liver Cancer Market by Geography (USD MN)
• Brain Cancer Market by Geography (USD MN)
• Colorectal Cancer Market by Geography (USD MN)
• Others Market by Geography (USD MN)
• Global Market Analysis by End-User (USD MN)
• Hospitals and Clinics Market by Geography (USD MN)
• Pharmacies Market by Geography (USD MN)
• Research Laboratories Market by Geography (USD MN)
• Others Market by Geography (USD MN)
• Global Market by Revenue
• North America Market by Revenue
• Europe Market by Revenue
• Asia Pacific Market by Revenue
• Latin America Market by Revenue
• Middle East & Africa Market by Revenue
• Recent Development in Industry
• Company Market Share Analysis
• Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.